Protein Domain Specific Covalent Inhibition of Human DNA Polymerase β

Shelby C. Yuhas, Ananya Majumdar, Marc M. Greenberg

Research output: Contribution to journalArticlepeer-review

Abstract

DNA polymerase β (Pol β) is a frequently overexpressed and/or mutated bifunctional repair enzyme. Pol β possesses polymerase and lyase active sites, that are employed in two steps of base excision repair. Pol β is an attractive therapeutic target for which there is a need for inhibitors. Two mechanistically inspired covalent inhibitors (1, IC50=21.0 μM; 9, IC50=18.7 μM) that modify lysine residues in different Pol β active sites are characterized. Despite modifying lysine residues in different active sites, 1 and 9 inactivate the polymerase and lyase activities of Pol β. Fluorescence anisotropy experiments indicate that they do so by preventing DNA binding. Inhibitors 1 and 9 provide the basis for a general approach to preparing domain selective inhibitors of bifunctional polymerases. Such molecules could prove to be useful tools for studying the role of wild type and mutant forms of Pol β and other polymerases in DNA repair.

Original languageEnglish (US)
Pages (from-to)2619-2623
Number of pages5
JournalChemBioChem
Volume22
Issue number16
DOIs
StatePublished - Aug 17 2021
Externally publishedYes

Keywords

  • DNA damage
  • DNA polymerases
  • DNA repair
  • covalent inhibitors
  • enzyme inhibition

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Protein Domain Specific Covalent Inhibition of Human DNA Polymerase β'. Together they form a unique fingerprint.

Cite this